• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
  • Cafepharma also has message boards for retail pharmacies: click here to view

Edit tags

Multiple tags may be separated by commas.